ArticleNeuropsychiatric disease and treatment2019

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.

Ashish Kumar Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.